Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura-Ancuta Pop

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Diagnostics (Basel, Switzerland)|May 4, 2026
Molecular Diagnosis and Phenotypic Variability of Noonan Syndrome: Experience from a Romanian Multicenter StudyFlorina Victoria Nazarie, Mihaela Amelia Dobrescu, Cecilia Lazea, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 24, 2015
Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon CancerFlorin Zaharie, Mihai Stefan Muresan, Bobe Petrushev, et al.
Medicina (Kaunas, Lithuania)|July 2, 2021
Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors-A Breakthrough in the Treatment of Cancer Patients with Febrile NeutropeniaCălin Căinap, Sânziana Cetean-Gheorghe, Laura Ancuta Pop, et al.
Cell Death & Disease|January 21, 2018
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expressionDiana Gulei, Lorand Magdo, Ancuta Jurj, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 14, 2020
New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cellsCristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 17, 2020
Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cellsCristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, et al.
Pharmaceutics|June 2, 2021
Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 GeneDiana Cenariu, Alina-Andreea Zimta, Raluca Munteanu, et al.
Plos One|April 28, 2021
Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysisCalin Cainap, Rodica Ana Ungur, Ovidiu-Vasile Bochis, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Diagnostics (Basel, Switzerland)|May 4, 2026
Molecular Diagnosis and Phenotypic Variability of Noonan Syndrome: Experience from a Romanian Multicenter StudyFlorina Victoria Nazarie, Mihaela Amelia Dobrescu, Cecilia Lazea, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 24, 2015
Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon CancerFlorin Zaharie, Mihai Stefan Muresan, Bobe Petrushev, et al.
Medicina (Kaunas, Lithuania)|July 2, 2021
Continuous Intravenous Administration of Granulocyte-Colony-Stimulating Factors-A Breakthrough in the Treatment of Cancer Patients with Febrile NeutropeniaCălin Căinap, Sânziana Cetean-Gheorghe, Laura Ancuta Pop, et al.
Cell Death & Disease|January 21, 2018
The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expressionDiana Gulei, Lorand Magdo, Ancuta Jurj, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 14, 2020
New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cellsCristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 17, 2020
Correction to: New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cellsCristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, et al.
Pharmaceutics|June 2, 2021
Hsa-miR-125b Therapeutic Role in Colon Cancer Is Dependent on the Mutation Status of the TP53 GeneDiana Cenariu, Alina-Andreea Zimta, Raluca Munteanu, et al.
Plos One|April 28, 2021
Partnering bevacizumab with irinotecan as first line-therapy of metastatic colorectal cancer improves progression free survival-A retrospective analysisCalin Cainap, Rodica Ana Ungur, Ovidiu-Vasile Bochis, et al.
Pageof 4